Amazon will begin trading on a 20-for-1 split adjusted basis Monday, with investors pegging its opening bell price at around $125 per share.

Inflation is raging, with consumer prices soaring 8.3% in the 12 months through April.

Vertex is one step closer to getting its new pain pill approved, which could substitute for opioids that are highly addictive.

Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.

"High energy prices are largely a result of underinvestment by many in the energy industry over the last several years and especially during the pandemic," Exxon said.

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

A brief overnight inversion of the U.S. yield curve, as well as mounting signs of a near-term recession, have stocks on the back foot heading into the holiday-shortened week.